Engineered Oxynitrilase for Enantioselective Henry Reaction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing biocatalytic methods for synthesizing β-nitro alcohols, such as the Henry reaction, face challenges with long reaction times, extreme conditions, and insufficient selectivities, and there is a need for enzymes that can enantioselectively catalyze this reaction with improved substrate scope and efficiency.

Innovation Solution

Engineered oxynitrilase polypeptides derived from Baliospermum montanum (BmHNL) with specific amino acid modifications through directed evolution, enabling high stereoselectivity and stability for the Henry reaction, particularly with electron withdrawing group-containing substrates, producing β-nitro alcohols with high yield and enantiomeric excess.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional chemical catalysts (non-enzymatic organocatalysts or chiral metal catalysts) are used for the Henry reaction, then the reaction can proceed, but the reaction times are long and sometimes extreme reaction conditions are required

Engineering Contradiction:
Improvereaction timeVSAvoidreaction conditions
Core Design Contradiction:
ProductivityVSTemperature

Solution Approach 1:

The patent applies parameter changes by modifying the enzyme's amino acid sequence through directed evolution to optimize catalytic parameters. Specific mutations (e.g., F27Y, F27W, F27L, F27P) were introduced to change the enzyme's substrate binding properties and catalytic efficiency, enabling the reaction to proceed under milder conditions with shorter reaction times while maintaining high enantioselectivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent replaces traditional chemical catalysis mechanisms (organocatalysts or metal catalysts) with an engineered enzymatic system. The oxynitrilase enzyme provides a biocatalytic mechanism that operates under physiological conditions, eliminating the need for extreme temperatures or pressures required by chemical catalysts, while achieving faster reaction rates and superior enantioselectivity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Manufacturing precision

If traditional organocatalysts are used for the Henry reaction, then the reaction can proceed, but the selectivities are insufficient

Engineering Contradiction:
ImproveenantioselectivityVSAvoidreaction efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent applies local quality by introducing specific point mutations at particular positions (e.g., position 27: F27Y, F27W, F27L, F27P) within the enzyme's active site. These localized amino acid substitutions create a chiral environment that selectively stabilizes the transition state for one enantiomer, achieving high enantioselectivity (up to 98% ee) without compromising overall catalytic efficiency

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent utilizes asymmetry by engineering the enzyme's active site to create an asymmetric chiral environment. The introduced amino acid mutations (particularly at position 27) generate steric and electronic asymmetry that discriminates between prochiral substrates, enabling preferential formation of one enantiomer while maintaining high reaction rates

Inventive Principle:
Principle #4Asymmetry

3Adaptability or versatility

If wild-type oxynitrilase is used for the Henry reaction, then the reaction can proceed, but the substrate scope is limited and stereoselectivity is insufficient

Engineering Contradiction:
Improvesubstrate scopeVSAvoidstereoselectivity
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent achieves universality by engineering the oxynitrilase enzyme to accept a broad range of substrates including various aldehydes and ketones with different functional groups (electron-withdrawing groups, aromatic rings, aliphatic chains). The engineered enzyme maintains catalytic activity and high stereoselectivity across diverse substrate types, transforming a specialized enzyme into a versatile biocatalyst for the Henry reaction

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent applies parameter changes through directed evolution to optimize both substrate binding affinity and stereoselectivity simultaneously. The introduced mutations (e.g., F27Y, F27W, F27L, F27P) modify the active site's steric and electronic parameters, enabling the enzyme to accommodate diverse substrates while maintaining precise stereochemical control through enhanced transition state stabilization

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered polypeptides achieve high stereoselectivity and stability, allowing efficient synthesis of β-nitro alcohols like (S)-1,1,1-trifluoro-2-methyl-3-nitropropan-2-ol with enantiomeric excess greater than 80%, offering an attractive alternative to traditional chemical synthesis and reducing chemical waste.

Implementation Method 1

an aldehyde or ketone compound is converted to the corresponding β-nitro alcohol compound in the presence of a nitroalkane compound and an engineered oxynitrilase

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

engineered oxynitrilase which enantioselectively catalyzes the Henry reaction

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS20250361500A1(s)-engineered oxynitrilase polypeptides and uses thereof
Publication Date: 2025.11.27 NOVARTIS AG
  • US20250361500A1 patent drawing
  • US20250361500A1 patent drawing
  • US20250361500A1 patent drawing

AI summary

The present disclosure relates to a process for producing chiral β-nitro alcohol compounds. The invention relates in particular to an (S)-selective oxynitrilase, which enantioselectively can catalyze the Henry reaction, wherein an aldehyde or ketone compound is converted to the corresponding β-nitro alcohol compound in the presence of a nitroalkane compound and an oxynitrilase.